CURRENT Medical Diagnosis and
Treatment 2026
65th Edition
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
PART 1 — DISEASE PREVENTION & HEALTH PROMOTION (5
items)
1) Reference
Ch. 1 — Disease Prevention & Health Promotion —
Immunizations. AccessMedicine
Question Stem:
A 68-year-old woman with well-controlled type 2 diabetes
reports she never received zoster vaccination. Which is the best
recommendation?
,Options:
A. Administer live attenuated zoster vaccine (single dose).
B. Administer recombinant zoster vaccine (two-dose series).
C. No vaccination is indicated because diabetes is well
controlled.
D. Prescribe daily acyclovir prophylaxis instead of vaccination.
Correct Answer: B
Rationales:
• B (Correct): Recombinant zoster vaccine (RZV) is
recommended for adults ≥50 (and especially for those ≥60)
including patients with diabetes; it is given as a two-dose
series to prevent herpes zoster and complications. This is
the preferred vaccine over the older live vaccine.
• A: The live zoster vaccine is no longer preferred for most
adults because RZV provides superior efficacy and longer
protection.
• C: Well-controlled diabetes is not a contraindication; in
fact, diabetes increases zoster risk and supports
vaccination.
• D: Antiviral prophylaxis (acyclovir) is not recommended for
zoster prevention in immunocompetent older adults—
vaccination is the appropriate preventive measure.
Teaching Point:
Recombinant zoster vaccine (RZV) — two doses — is preferred
for adults ≥50.
,Citation (Simplified APA):
Papadakis et al. (2025). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.). Ch. 1.
2) Reference
Ch. 1 — Disease Prevention & Health Promotion — Lung Cancer
Screening. AccessMedicine
Question Stem:
A 58-year-old man with a 30-pack-year smoking history
currently smokes. He asks whether he should have lung cancer
screening. Which is the correct recommendation?
Options:
A. No screening unless he has symptoms.
B. Annual low-dose computed tomography (LDCT) because he
meets USPSTF criteria.
C. Annual chest radiograph (CXR) is the recommended
screening test.
D. Sputum cytology every 6 months is recommended for heavy
smokers.
Correct Answer: B
Rationales:
• B (Correct): Adults meeting age and pack-year criteria (per
USPSTF/CMDT guidance) should be offered annual LDCT
, for early lung cancer detection. A 30-pack-year current
smoker at age 58 typically meets screening criteria.
• A: Waiting for symptoms misses early, potentially curable
disease; screening is indicated in eligible individuals.
• C: Chest radiograph is not sensitive for early lung cancer
and is not the recommended screening tool.
• D: Sputum cytology is not an accepted replacement for
LDCT for screening.
Teaching Point:
Offer annual LDCT to eligible adults with significant smoking
history.
Citation (Simplified APA):
Papadakis et al. (2025). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.). Ch. 1.
3) Reference
Ch. 1 — Disease Prevention & Health Promotion — Colorectal
Cancer Screening. AccessMedicine
Question Stem:
A 51-year-old woman with no GI symptoms asks about
colorectal cancer screening. Which option is the best initial
recommendation?
Options:
A. Begin screening at age 55 with colonoscopy every 10 years.
Treatment 2026
65th Edition
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
PART 1 — DISEASE PREVENTION & HEALTH PROMOTION (5
items)
1) Reference
Ch. 1 — Disease Prevention & Health Promotion —
Immunizations. AccessMedicine
Question Stem:
A 68-year-old woman with well-controlled type 2 diabetes
reports she never received zoster vaccination. Which is the best
recommendation?
,Options:
A. Administer live attenuated zoster vaccine (single dose).
B. Administer recombinant zoster vaccine (two-dose series).
C. No vaccination is indicated because diabetes is well
controlled.
D. Prescribe daily acyclovir prophylaxis instead of vaccination.
Correct Answer: B
Rationales:
• B (Correct): Recombinant zoster vaccine (RZV) is
recommended for adults ≥50 (and especially for those ≥60)
including patients with diabetes; it is given as a two-dose
series to prevent herpes zoster and complications. This is
the preferred vaccine over the older live vaccine.
• A: The live zoster vaccine is no longer preferred for most
adults because RZV provides superior efficacy and longer
protection.
• C: Well-controlled diabetes is not a contraindication; in
fact, diabetes increases zoster risk and supports
vaccination.
• D: Antiviral prophylaxis (acyclovir) is not recommended for
zoster prevention in immunocompetent older adults—
vaccination is the appropriate preventive measure.
Teaching Point:
Recombinant zoster vaccine (RZV) — two doses — is preferred
for adults ≥50.
,Citation (Simplified APA):
Papadakis et al. (2025). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.). Ch. 1.
2) Reference
Ch. 1 — Disease Prevention & Health Promotion — Lung Cancer
Screening. AccessMedicine
Question Stem:
A 58-year-old man with a 30-pack-year smoking history
currently smokes. He asks whether he should have lung cancer
screening. Which is the correct recommendation?
Options:
A. No screening unless he has symptoms.
B. Annual low-dose computed tomography (LDCT) because he
meets USPSTF criteria.
C. Annual chest radiograph (CXR) is the recommended
screening test.
D. Sputum cytology every 6 months is recommended for heavy
smokers.
Correct Answer: B
Rationales:
• B (Correct): Adults meeting age and pack-year criteria (per
USPSTF/CMDT guidance) should be offered annual LDCT
, for early lung cancer detection. A 30-pack-year current
smoker at age 58 typically meets screening criteria.
• A: Waiting for symptoms misses early, potentially curable
disease; screening is indicated in eligible individuals.
• C: Chest radiograph is not sensitive for early lung cancer
and is not the recommended screening tool.
• D: Sputum cytology is not an accepted replacement for
LDCT for screening.
Teaching Point:
Offer annual LDCT to eligible adults with significant smoking
history.
Citation (Simplified APA):
Papadakis et al. (2025). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.). Ch. 1.
3) Reference
Ch. 1 — Disease Prevention & Health Promotion — Colorectal
Cancer Screening. AccessMedicine
Question Stem:
A 51-year-old woman with no GI symptoms asks about
colorectal cancer screening. Which option is the best initial
recommendation?
Options:
A. Begin screening at age 55 with colonoscopy every 10 years.
